JOHNSON & JOHNSON
JNJ
51 insider filings · Latest: Aug 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Feb 18 4:14 PM | Schmid Timothy | Proposed Sale | 22,623 | $244.33 | $5.5M | — | View → |
| Feb 17, 2026 | Feb 17 9:10 PM | Broadhurst Vanessa | Proposed Sale | 6,197 | $243.39 | $1.5M | — | View → |
| Feb 17, 2026 | Feb 17 7:52 PM | Swanson James D. | Proposed Sale | 20,521 | $242.70 | $5.0M | — | View → |
| Feb 17, 2026 | Feb 17 7:43 PM | Wolk Joseph J | Proposed Sale | 89,654 | $242.80 | $21.8M | — | View → |
| Feb 17, 2026 | Feb 17 5:44 PM | REED JOHN C | Proposed Sale | 53,931 | $243.00 | $13.1M | — | View → |
| Feb 13, 2026 | Feb 13 7:33 PM | Swanson James D. | Proposed Sale | 41,559 | $243.73 | $10.1M | — | View → |
| Feb 5, 2026 | Feb 5 9:31 PM | Forminard Elizabeth | Proposed Sale | 6,226 | $237.90 | $1.5M | — | View → |
| Jan 26, 2026 | Jan 28 11:07 PM | Joaquin DuatoDirector, CEO and Chairman of the Board | Sale | 100,000 | $221.23 | $22.1M | 30,852(I) | View → |
| Jan 26, 2026 | Jan 26 9:57 PM | Joaquin Duato | Proposed Sale | 100,000 | $220.14 | $22.0M | — | View → |
| Oct 17, 2025 | Oct 17 2:23 PM | REED JOHN C | Proposed Sale | 21,721 | $192.71 | $4.2M | — | View → |
| Sep 4, 2025 | Sep 4 6:37 PM | Taubert Jennifer L | Proposed Sale | 56,471 | $177.81 | $10.0M | — | View → |
| Aug 29, 2025 | Aug 29 7:36 PM | Forminard Elizabeth | Proposed Sale | 9,570 | $177.20 | $1.7M | — | View → |
| Aug 22, 2025 | Aug 22 5:58 PM | Duato Joaquin | Proposed Sale | 125,824 | $180.04 | $22.7M | — | View → |
| Aug 15, 2025 | Aug 15 7:57 PM | Wolk Joseph J | Proposed Sale | 16,820 | $176.91 | $3.0M | — | View → |
| Jul 17, 2025 | Jul 17 8:05 PM | REED JOHN C | Proposed Sale | 19,137 | $163.55 | $3.1M | — | View → |
| Feb 25, 2025 | Feb 25 8:05 PM | Decker Robert J | Proposed Sale | 6,999 | $165.88 | $1.2M | — | View → |
| Feb 7, 2025 | Feb 7 6:27 PM | Wolk Joseph J | Proposed Sale | 13,015 | $153.89 | $2.0M | — | View → |
| Dec 4, 2024 | Dec 4 6:25 PM | Hait William | Proposed Sale | 25,742 | $149.90 | $3.9M | — | View → |
| Aug 30, 2024 | Aug 30 7:51 PM | Decker Robert J | Proposed Sale | 5,635 | $165.06 | $930.1K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Feb 12 1:47 AM | Joseph J WolkExec VP, CFO | Grant/Award | 37,463 | — | 37,463(D) | View → |
| Feb 9, 2026 | Feb 12 1:45 AM | Jennifer L TaubertEVP, WWC. Innovative Medicine | Grant/Award | 27,412 | — | 27,412(D) | View → |
| Feb 9, 2026 | Feb 12 1:43 AM | James D. SwansonEVP, CIO | Grant/Award | 9,412 | — | 9,412(D) | View → |
| Feb 9, 2026 | Feb 12 1:41 AM | Timothy SchmidEVP, WW Chair, MedTech | Grant/Award | 4,378 | — | 4,378(D) | View → |
| Feb 9, 2026 | Feb 12 1:39 AM | Kristen MulhollandEVP, Chief HR Officer | Grant/Award | 3,602 | — | 3,602(D) | View → |
| Feb 9, 2026 | Feb 12 1:37 AM | Elizabeth ForminardEVP, Chief Legal Officer | Grant/Award | 13,706 | — | 13,706(D) | View → |
| Feb 9, 2026 | Feb 12 1:34 AM | Joaquin DuatoDirector, CEO and Chairman of the Board | Grant/Award | 73,054 | — | 73,054(D) | View → |
| Feb 9, 2026 | Feb 12 1:33 AM | Robert J DeckerVP Corporate Controller | Grant/Award | 2,741 | — | 2,741(D) | View → |
| Feb 9, 2026 | Feb 12 1:28 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Grant/Award | 13,706 | — | 13,706(D) | View → |
| Feb 9, 2026 | Feb 12 1:24 AM | Vanessa BroadhurstEVP, Global Corp Affairs | Grant/Award | 8,594 | — | 8,594(D) | View → |
| Feb 6, 2026 | Feb 11 2:46 AM | Timothy SchmidEVP, WW Chair, MedTech | Option Exercise | 15,571 | $101.87 | 0(D) | View → |
| Feb 6, 2026 | Feb 10 12:42 AM | Kristen MulhollandEVP, Chief HR Officer | Option Exercise | 5,625 | $101.87 | 0(D) | View → |
| Feb 6, 2026 | Feb 10 12:40 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Option Exercise | 38,945 | $101.87 | 0(D) | View → |
| Feb 5, 2026 | Feb 6 10:46 PM | Elizabeth ForminardEVP, Chief Legal Officer | Option Exercise | 8,921 | $129.51 | 0(D) | View → |
← Previous
Page 4 of 4